Steven Kayser, PharmD


Steven R. Kayser is a clinical pharmacist at the UCSF Anticoagulation Clinic. He also holds the title of professor emeritus in the department of clinical pharmacy at UCSF. He specializes in the treatment of blood clots associated with atrial fibrillation, deep venous thrombosis, pulmonary embolism, stroke and hereditary thrombophilias, as well as the perioperative management of anticoagulants. His research interests include antithrombotic drugs, perioperative management of anticoagulants and the application of new drugs to prevent blood clot problems. For over 35 years, Kayser has travelled around the world serving as a visiting professor in countries such as Japan, Thailand, England and Singapore.

Kayser earned a doctor of pharmacy (Pharm.D.) at the UCSF School of Pharmacy. He is the recipient of numerous prestigious awards, such as the UCSF Preceptor of the Year Award, Clinical Pharmacy Residents and UCSF Dean's Recognition for Excellence in Teaching. Kayser is a member of various professional organizations including the American College of Clinical Pharmacy, American Association of Colleges of Pharmacy, Society of Critical Care Medicine and American Society of Health-Systems Pharmacists.


Anticoagulation Clinic
350 Parnassus Ave., Fourth Floor, Suite 410
San Francisco, CA 94143-0325
Phone: (415) 353-2143
Fax: (415) 353-2890

Hours: 8:30 a.m. – 4:30 p.m.

Academic Title

Professor Emeritus

Selected Research and Publications

  1. Alldredge BK, Kayser SR. In reply. JAMA Intern Med. 2013 Aug 12; 173(15):1473.
  2. Alldredge BK, Kayser SR. Bending the curve toward increased use of generic drugs. JAMA Intern Med. 2013 Feb 11; 173(3):233-4.
  3. Johnson SG, Kayser SR, Attridge RL, Duvall L, Kiser TH, Moote R, Reed BN, Rodgers JE, Erstad B. Key articles and guidelines in the management of pulmonary arterial hypertension: 2011 update. Pharmacotherapy. 2012 Jun; 32(6):e134-69.
  4. Shin J, Kayser SR. Accuracy of the pharmacogenetic dosing table in the warfarin label in predicting initial therapeutic warfarin doses in a large, racially diverse cohort. Pharmacotherapy. 2011 Sep; 31(9):863-70.
  5. Cheng CM, McCurdy MR, Wong HA, Kayser SR. Pros and cons of dabigatran. Am J Health Syst Pharm. 2011 Aug 15; 68(16):1495.
  6. Meeker E, Dennehy CE, Weber EJ, Kayser SR. Emergency department management of patients on warfarin therapy. Ann Emerg Med. 2011 Aug; 58(2):192-9.
  7. Kadafour M, Haugh R, Posin M, Kayser SR, Shin J. Survey on warfarin pharmacogenetic testing among anticoagulation providers. Pharmacogenomics. 2009 Nov; 10(11):1853-60.
  8. Shin J, Kayser SR, Langaee TY. Pharmacogenetics: from discovery to patient care. Am J Health Syst Pharm. 2009 Apr 01; 66(7):625-37.
  9. Cheng CM, Meyer-Massetti C, Kayser SR. A review of three stand-alone topical thrombins for surgical hemostasis. Clin Ther. 2009 Jan; 31(1):32-41.
  10. Kayser SR. Dronedarone: in quest of the ideal antiarrhythmic drug. Prog Cardiovasc Nurs. 2007; 22(4):221-4.
  11. Kayser SR. Pharmacogenomics and the potential for personalized therapeutics in cardiovascular disease. Prog Cardiovasc Nurs. 2007; 22(2):104-7.
  12. Kayser SR. The use of nesiritide in the management of acute decompensated heart failure. 2002. Prog Cardiovasc Nurs. 2007; 22(4):89-95.
  13. Boettger R, Lee J, Rifkin C, Kayser SR. Heart transplantation and altered drug response, Part II: pharmacologic management of post-transplantation complications. Prog Cardiovasc Nurs. 2006; 21(4):219-22.
  14. Boettger R, Lee J, Rifkin C, Kayser S. Heart transplantation and altered drug response, part I: heart transplantation and innervation. Prog Cardiovasc Nurs. 2006; 21(2):100-3.
  15. Dang MT, Hambleton J, Kayser SR. The influence of ethnicity on warfarin dosage requirement. Ann Pharmacother. 2005 Jun; 39(6):1008-12.
  16. Kayser SR. Combination drug therapy in the management of pulmonary arterial hypertension. Prog Cardiovasc Nurs. 2005; 20(4):177-82.
  17. Kayser SR. Practical challenges in the management of oral anticoagulation. Prog Cardiovasc Nurs. 2005; 20(2):80-5.
  18. Voirol P, Kayser SR, Chang CY, Chang QL, Youmans SL. Impact of pharmacists' interventions on the pediatric discharge medication process. Ann Pharmacother. 2004 Oct; 38(10):1597-602.
  19. Lee KW, Kayser SR, Hongo RH, Tseng ZH, Scheinman MM. Famotidine and long QT syndrome. Am J Cardiol. 2004 May 15; 93(10):1325-7.
  20. Kayser SR. Dilemmas in drug therapy. Prog Cardiovasc Nurs. 2003; 18(2):108-11.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.